Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease

References

• Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–645.
   PubMed Web of Science ®Google Scholar
• Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19(4):789–799.
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145(1):166–175 e8.
   PubMed Web of Science ®Google Scholar
• Olen O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020;395(10218):123–131.
   PubMed Web of Science ®Google Scholar
• Olen O, Erichsen R, Sachs MC, et al. Colorectal cancer in Crohn’s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol Hepatol. 2020;5:475–484.
   PubMed Web of Science ®Google Scholar
• Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39(7):645–659.
   PubMed Web of Science ®Google Scholar
• Jess T, Simonsen J, Jorgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143(2):375–381.
   PubMed Web of Science ®Google Scholar
• Klepp P, Brackmann S, Cvancarova M, et al. Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterol. 2020;7(1):e000361.
   PubMed Web of Science ®Google Scholar
• Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
   PubMed Web of Science ®Google Scholar
• Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–689.
   PubMed Web of Science ®Google Scholar
• Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.
   PubMed Web of Science ®Google Scholar
• Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):738–745.
   PubMed Web of Science ®Google Scholar
• Baars JE, Kuipers EJ, van Haastert M, et al. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol. 2012;47(12):1308–1322.
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53(12):1813–1816.
   PubMed Web of Science ®Google Scholar
• Mahmoud R, Shah SC, Ten Hove JR, et al. No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases. Gastroenterology. 2019;156(5):1333–1344.e3.
   PubMed Web of Science ®Google Scholar
• Choi CR, Al Bakir I, Ding NJ, et al. Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-Centre study. Gut. 2019;68(3):414–422.
   PubMedGoogle Scholar
• Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56(1):48–54.
   PubMed Web of Science ®Google Scholar
• Sorensen JO, Nielsen OH, Andersson M, et al. Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977–2011. Liver Int. 2018;38(3):532–541.
   PubMed Web of Science ®Google Scholar
• Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120(6):1356–1362.
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–260.
   PubMed Web of Science ®Google Scholar
• Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2018;67(4):616–624.
   PubMed Web of Science ®Google Scholar
• Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103(9):2342–2349.
   PubMed Web of Science ®Google Scholar
• Choi CH, Rutter MD, Askari A, et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015;110(7):1022–1034.
   PubMed Web of Science ®Google Scholar
• Brackmann S, Andersen SN, Aamodt G, et al. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Scand J Gastroenterol. 2009;44(1):46–55.
   PubMed Web of Science ®Google Scholar
• Lutgens MW, Vleggaar FP, Schipper MEI, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 2008;57(9):1246–1251.
   PubMed Web of Science ®Google Scholar
• Jess T. Are we missing 1 in 5 of colorectal cancers? Inflamm Bowel Dis. 2009;15(1):154–155.
   PubMed Web of Science ®Google Scholar
• Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42(1):1–10.
   PubMed Web of Science ®Google Scholar
• Thorlacius H, Takeuchi Y, Kanesaka T, et al. Serrated polyps - a concealed but prevalent precursor of colorectal cancer. Scand J Gastroenterol. 2017;52(6–7):654–661.
   PubMed Web of Science ®Google Scholar
• Rubio CA, Befrits R, Jaramillo E, et al. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res. 2000;20(6C):4761–4764.
   PubMed Web of Science ®Google Scholar
• Soetikno R, Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology. 2013;144(7):1349–1352.
   PubMed Web of Science ®Google Scholar
• Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81(3):489–501.e26.
   PubMed Web of Science ®Google Scholar
• Kaltenbach TR, Soetikno RM, DeVivo R, et al. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching. Gastrointest Endosc. 2017;86(6):1107–1117.e1.
   PubMed Web of Science ®Google Scholar
• Soetikno R, Sanduleanu S, Kaltenbach T. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014;24(3):483–520.
   PubMedGoogle Scholar
• Bisschops R, Bessissow T, Joseph JA, et al. Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial. Gut. 2018;67(6):1087–1094.
   PubMed Web of Science ®Google Scholar
• Imperatore N, Castiglione F, Testa A, et al. Augmented endoscopy for surveillance of colonic inflammatory bowel disease: systematic review with network meta-analysis. J Crohns Colitis. 2019;13(6):714–724.
   PubMed Web of Science ®Google Scholar
• The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003. 58:S3–S43.
   PubMed Web of Science ®Google Scholar
• Iacucci M, Furfaro F, Matsumoto T, et al. Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era. Gut. 2018;68:562–572.
   PubMed Web of Science ®Google Scholar
• Iacucci M, McQuaid K, Gui XS, et al. A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 2019;51(2):133–141.
   PubMedGoogle Scholar
• Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151(6):1122–1130.
   PubMed Web of Science ®Google Scholar
• van den Broek FJ, Stokkers PC, Reitsma JB, et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol. 2014;109(5):715–722.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Kochhar G, Venkatesh PG, et al. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis. 2013;7(12):974–981.
   PubMed Web of Science ®Google Scholar
• Bisschops R, East JE, Hassan C, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2019. Endoscopy. 2019;51(12):1155–1179.
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130(4):1030–1038.
   PubMed Web of Science ®Google Scholar
• Bye WA, Nguyen TM, Parker CE, et al. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017;9:CD000279.
   PubMed Web of Science ®Google Scholar
• Filipe MI, Edwards MR, Ehsanullah M. A prospective study of dysplasia and carcinoma in the rectal biopsies and rectal stump of eight patients following ileorectal anastomosis in ulcerative colitis. Histopathology. 1985;9(11):1139–1153.
   PubMed Web of Science ®Google Scholar
• Oakley JR, Lavery IC, Fazio VW, et al. The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Dis Colon Rectum. 1985;28(6):394–396.
   PubMed Web of Science ®Google Scholar
• Baker WN, Glass RE, Ritchie JK, et al. Cancer of the rectum following colectomy and ileorectal anastomosis for ulcerative colitis. Br J Surg. 1978;65(12):862–868.
   PubMed Web of Science ®Google Scholar
• Das P, Johnson MW, Tekkis PP, et al. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis. 2007;9(1):15–27.
   PubMed Web of Science ®Google Scholar
• Veress B, Reinholt FP, Lindquist K, et al. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology. 1995;109(4):1090–1097.
   PubMed Web of Science ®Google Scholar
• Oxford Centre for Evidence-Based Medicine: Levels of Evidence [March 2009]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009.
   Google Scholar
• Kaltenbach T, Sandborn WJ. Endoscopy in inflammatory bowel disease: advances in dysplasia detection and management. Gastrointest Endosc. 2017;86(6):962–971. Epub 2017 Oct
   PubMed Web of Science ®Google Scholar
• Siegel CA, Schwartz LM, Woloshin S, et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010;16(10):1658–1662.
   PubMed Web of Science ®Google Scholar
• Baars JE, Siegel CA, van’t Spijker A, et al. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010;42(11):777–784.
   PubMedGoogle Scholar